Acelyrin shifts from lead candidate despite positive phase 3 results
Acelyrin will shift away from lead candidate and cut its workforce, despite izokibep’s encouraging phase 3 results in psoriatic arthritis and hidradenitis suppurativa
Archives for August 15, 2024
Gilead gains accelerated FDA approval for rare liver disease treatment
Gilead wins on new company acquisition with accelerated approval for autoimmune liver disease drug
Advice for young women in science - stay curious and inquisitive the rest will follow
Katarina Wikstrom has worked for over 20 years in the field of translational molecular oncology and holds the position of VP global product development at Almac Diagnostic Services.